Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ORMP
ORMP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORMP News
Oramed Pharmaceuticals and Lifeward Sign Strategic Deal, Investing $9 Million
Jan 13 2026
NASDAQ.COM
Oramed Pharmaceuticals Receives $18 Million Payment, Declares $0.25 Dividend
Jan 07 2026
Newsfilter
ORAMED PHARMACEUTICALS INC. ANNOUNCES DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS AS DIVIDEND
Nov 17 2025
Newsfilter
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Nov 17 2025
PRnewswire
Oramed Shares Update with Shareholders on Oral Insulin Program Progress, Notable Investment Gains, and Future Growth Plans
Oct 23 2025
Newsfilter
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Apr 28 2025
Newsfilter
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
Apr 28 2025
Newsfilter
Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical
Apr 28 2025
SeekingAlpha
Alpha Tau Closes $36.9 Mln Offering And Forms Strategic Alliance With Oramed Pharmaceuticals
Apr 01 2025
NASDAQ.COM
Oramed Pharmaceuticals Issues Letter to Shareholders
Mar 04 2025
PRnewswire
Oramed's New OraTech Venture Aims To Revolutionize Diabetes Care With Oral Insulin Delivery
Feb 11 2025
NASDAQ.COM
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Feb 11 2025
Newsfilter
Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Dec 16 2024
Newsfilter
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Oct 07 2024
Newsfilter
Sector Update: Health Care Stocks Decline Monday Afternoon
Sep 23 2024
NASDAQ.COM
HC Wainwright & Co. Reiterates Neutral on Oramed Pharmaceuticals
Sep 09 2024
Benzinga
Show More News
